Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate

D. S. Vara, M. Campanella, I. Canobbio, W. B. Dunn, G. Pizzorno, M. Hirano, G. Pula

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Using direct injection mass spectrometry (DIMS) we discovered that deoxyribose-1-phosphate (dRP) is released by platelets upon activation. Interestingly, the addition of exogenous dRP to human platelets significantly increased platelet aggregation and integrin αIIbβ3 activation in response to thrombin. In parallel, genetically modified platelets with double genetic deletion of thymidine phosphorylase and uridine phosphorylase were characterised by reduced release of dRP, impaired aggregation and decreased integrin αIIbβ3 activation in response to thrombin. In vitro platelet adhesion onto fibrinogen and collagen under physiological flow conditions was potentiated by treatment of human platelets with exogenous dRP and impaired in transgenic platelets with reduced dRP release. Human and mouse platelets responded to dRP treatment with a sizeable increase in reactive oxygen species (ROS) generation and the pre-treament with the antioxidant apocynin abolished the effect of dRP on aggregation and integrin activation. Experiments directly assessing the activation of the small G protein Rap1b and protein kinase C suggested that dRP increases the basal levels of activity of these two pivotal platelet-activating pathways in a redox-dependent manner. Taken together, we present evidence that dRP is a novel autocrine amplifier of platelet activity, which acts on platelet redox levels and modulates integrin αIIbβ3
Original languageEnglish
Pages (from-to)1108-1119
JournalThrombosis and Haemostasis
Volume109
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Deoxyribose
Platelet Activation
Integrins
Adhesives
Blood Platelets
Phosphates
Thrombin
Oxidation-Reduction
Uridine Phosphorylase
Thymidine Phosphorylase
Monomeric GTP-Binding Proteins
Platelet Aggregation
Fibrinogen
Protein Kinase C
Reactive Oxygen Species
Mass Spectrometry
Collagen
Antioxidants
Injections

Cite this

Vara, D. S., Campanella, M., Canobbio, I., Dunn, W. B., Pizzorno, G., Hirano, M., & Pula, G. (2013). Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate. Thrombosis and Haemostasis, 109(6), 1108-1119. https://doi.org/10.1160/TH12-10-0751

Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate. / Vara, D. S.; Campanella, M.; Canobbio, I.; Dunn, W. B.; Pizzorno, G.; Hirano, M.; Pula, G.

In: Thrombosis and Haemostasis, Vol. 109, No. 6, 2013, p. 1108-1119.

Research output: Contribution to journalArticle

Vara, DS, Campanella, M, Canobbio, I, Dunn, WB, Pizzorno, G, Hirano, M & Pula, G 2013, 'Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate', Thrombosis and Haemostasis, vol. 109, no. 6, pp. 1108-1119. https://doi.org/10.1160/TH12-10-0751
Vara, D. S. ; Campanella, M. ; Canobbio, I. ; Dunn, W. B. ; Pizzorno, G. ; Hirano, M. ; Pula, G. / Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate. In: Thrombosis and Haemostasis. 2013 ; Vol. 109, No. 6. pp. 1108-1119.
@article{20b14e7c324d4783ac5a3713387712ec,
title = "Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate",
abstract = "Using direct injection mass spectrometry (DIMS) we discovered that deoxyribose-1-phosphate (dRP) is released by platelets upon activation. Interestingly, the addition of exogenous dRP to human platelets significantly increased platelet aggregation and integrin αIIbβ3 activation in response to thrombin. In parallel, genetically modified platelets with double genetic deletion of thymidine phosphorylase and uridine phosphorylase were characterised by reduced release of dRP, impaired aggregation and decreased integrin αIIbβ3 activation in response to thrombin. In vitro platelet adhesion onto fibrinogen and collagen under physiological flow conditions was potentiated by treatment of human platelets with exogenous dRP and impaired in transgenic platelets with reduced dRP release. Human and mouse platelets responded to dRP treatment with a sizeable increase in reactive oxygen species (ROS) generation and the pre-treament with the antioxidant apocynin abolished the effect of dRP on aggregation and integrin activation. Experiments directly assessing the activation of the small G protein Rap1b and protein kinase C suggested that dRP increases the basal levels of activity of these two pivotal platelet-activating pathways in a redox-dependent manner. Taken together, we present evidence that dRP is a novel autocrine amplifier of platelet activity, which acts on platelet redox levels and modulates integrin αIIbβ3",
author = "Vara, {D. S.} and M. Campanella and I. Canobbio and Dunn, {W. B.} and G. Pizzorno and M. Hirano and G. Pula",
year = "2013",
doi = "10.1160/TH12-10-0751",
language = "English",
volume = "109",
pages = "1108--1119",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "6",

}

TY - JOUR

T1 - Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate

AU - Vara, D. S.

AU - Campanella, M.

AU - Canobbio, I.

AU - Dunn, W. B.

AU - Pizzorno, G.

AU - Hirano, M.

AU - Pula, G.

PY - 2013

Y1 - 2013

N2 - Using direct injection mass spectrometry (DIMS) we discovered that deoxyribose-1-phosphate (dRP) is released by platelets upon activation. Interestingly, the addition of exogenous dRP to human platelets significantly increased platelet aggregation and integrin αIIbβ3 activation in response to thrombin. In parallel, genetically modified platelets with double genetic deletion of thymidine phosphorylase and uridine phosphorylase were characterised by reduced release of dRP, impaired aggregation and decreased integrin αIIbβ3 activation in response to thrombin. In vitro platelet adhesion onto fibrinogen and collagen under physiological flow conditions was potentiated by treatment of human platelets with exogenous dRP and impaired in transgenic platelets with reduced dRP release. Human and mouse platelets responded to dRP treatment with a sizeable increase in reactive oxygen species (ROS) generation and the pre-treament with the antioxidant apocynin abolished the effect of dRP on aggregation and integrin activation. Experiments directly assessing the activation of the small G protein Rap1b and protein kinase C suggested that dRP increases the basal levels of activity of these two pivotal platelet-activating pathways in a redox-dependent manner. Taken together, we present evidence that dRP is a novel autocrine amplifier of platelet activity, which acts on platelet redox levels and modulates integrin αIIbβ3

AB - Using direct injection mass spectrometry (DIMS) we discovered that deoxyribose-1-phosphate (dRP) is released by platelets upon activation. Interestingly, the addition of exogenous dRP to human platelets significantly increased platelet aggregation and integrin αIIbβ3 activation in response to thrombin. In parallel, genetically modified platelets with double genetic deletion of thymidine phosphorylase and uridine phosphorylase were characterised by reduced release of dRP, impaired aggregation and decreased integrin αIIbβ3 activation in response to thrombin. In vitro platelet adhesion onto fibrinogen and collagen under physiological flow conditions was potentiated by treatment of human platelets with exogenous dRP and impaired in transgenic platelets with reduced dRP release. Human and mouse platelets responded to dRP treatment with a sizeable increase in reactive oxygen species (ROS) generation and the pre-treament with the antioxidant apocynin abolished the effect of dRP on aggregation and integrin activation. Experiments directly assessing the activation of the small G protein Rap1b and protein kinase C suggested that dRP increases the basal levels of activity of these two pivotal platelet-activating pathways in a redox-dependent manner. Taken together, we present evidence that dRP is a novel autocrine amplifier of platelet activity, which acts on platelet redox levels and modulates integrin αIIbβ3

UR - http://www.scopus.com/inward/record.url?scp=84878627332&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1160/TH12-10-0751

U2 - 10.1160/TH12-10-0751

DO - 10.1160/TH12-10-0751

M3 - Article

VL - 109

SP - 1108

EP - 1119

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 6

ER -